The AACE has updated its guidance on obesity and adiposity-based chronic disease to reflect a focus on improving overall ...
The Obesity Association, a division of the American Diabetes Association (ADA), has issued new standards of care on the ...
Hosted on MSN
Semaglutide, tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance
Semaglutide or tirzepatide should be the first line treatment for people living with obesity and most of its complications, according to a new framework for the pharmacological treatment of obesity ...
"The establishment of the Obesity Association, and now its associated journal, marks a significant advancement toward a future where the management of cardiometabolic diseases is unified, proactive, ...
AAP recommends a multimodal approach to childhood obesity, including lifestyle changes, pharmacotherapy, and bariatric surgery, emphasizing early intervention and expanded treatment access. Addressing ...
A deep dive into the scientific shift toward multi-target obesity therapeutics and its implications for metabolic health and ...
Utilization of AOMs and MBS is low, with disparities based on race, education, and insurance coverage influencing treatment access. Insurance coverage significantly impacts treatment likelihood, with ...
Please provide your email address to receive an email when new articles are posted on . AAP began recommending weight-loss medications for adolescents with obesity in 2023. Providers prescribed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results